Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Harvard Business School
Moodys
Dow
AstraZeneca
McKinsey
McKesson

Last Updated: February 22, 2020

DrugPatentWatch Database Preview

Litigation Details for Amgen Inc. v. Amneal Pharmaceuticals (D. Del. 2016)


Email this page to a colleague

See Plans and Pricing

« Back to Dashboard

Amgen Inc. v. Amneal Pharmaceuticals (D. Del. 2016)

Docket   Start Trial Date Filed 2016-09-22
Court District Court, D. Delaware Date Terminated
Cause 35:271 Patent Infringement Assigned To Gregory Moneta Sleet
Jury Demand None Referred To
Parties ACTAVIS PHARMA, INC.; AJANTA PHARMA LIMITED; AJANTA PHARMA USA INC.; AMGEN INC.; AMNEAL PHARMACEUTICALS LLC; AMNEAL PHARMACEUTICALS OF NEW YORK LLC; APOTEX CORP.; APOTEX INC.; AUROBINDO PHARMA LTD.; AUROBINDO PHARMA USA INC.; BRECKENRIDGE PHARMACEUTICAL INC.; CADILA HEALTHCARE LTD.; CIPLA LIMITED; CIPLA LTD.; CIPLA USA INC.; CIPLA USA, INC.; DR. REDDYS LABORATORIES, INC.; DR. REDDYS LABORATORIES, LTD.; HETERO LABS LTD.; HETERO LABS LTD. UNIT V; HETERO USA INC.; MICRO LABS LIMITED; MICRO LABS USA, INC.; MYLAN INC.; MYLAN PHARMACEUTICALS INC.; PIRAMAL HEALTHCARE LIMITED; STRIDES PHARMA GLOBAL PTE LIMITED; STRIDES PHARMA INC.; SUN PHARMA GLOBAL FZE; SUN PHARMACEUTICAL INDUSTRIES LTD.; SUN PHARMACEUTICAL INDUSTRIES LTD.,; SUN PHARMACEUTICAL INDUSTRIES, INC.; WATSON LABORATORIES, INC.; ZYDUS PHARMACEUTICALS (USA) INC.
Patents 10,183,004; 6,011,068; 6,211,244; 6,316,460; 9,375,405
Attorneys Aaron F. Barkoff; Alan Richard Silverstein; Alejandro Menchaca; Anil H. Patel; Arun John Mohan; Bindu Ann George Palapura; Brian E. Farnan; C. Kyle Musgrove; Caroline L. Marsili; Christopher B. Essig; Courtney S. Dabbiere; David A. Bilson; David Clay Holloway; David Ellis Moore; David M. Fry; Deepro R. Mukerjee; Derek James Fahnestock; Derek S. Neilson; Dominick T. Gattuso; Elizabeth E. Grden; Elizabeth J. Weiskopf; Elizabeth M. Crompton; Gene A. Lang; George C. Lombardi; Gregory C. Bays; Iams J. Travis; Ian Scott; J. Clayton Athey; Jack B. Blumenfeld; Jaimin H. Shah; Jake M. Holdreith; James S. Green; Jared Thomas Green; John C. Phillips , Jr.; John K. Hsu; John W. Bateman; John W. Shaw; Joseph J. Bellew; Joseph James Bellew; Joseph M. Bennett-Paris; Joseph M. Janusz; Joshua H. Lee; Karen Elizabeth Keller; Kasey E. Koballa; Kaveh Saba; Kaveh V. Saba; Kelsey J. McElveen; Kelsey J. Thorkelson; Kenneth Laurence Dorsney; Lance A Soderstrom; Lance A. Soderstrom; Marilyn Neiman; Mark S. Schuman; Martin B. Pavane; Mary Matterer; Maryellen Noreika; Michael J. Farnan; Mitchell G. Stockwell; Oren D. Langer; Philip Y. Kouyoumdjian; Rajendra A. Chiplunkar; Samuel T. Lockner; Sara E. Bussiere; Stamatios Stamoulis; Stephanie E. O'Byrne; Stephanie M. Roberts; Stephen B. Brauerman; Steven A. Maddox; Tara L. Feld; William D. Hare; Zachary L. Sorman
Firms Bayard, P.A.; Farnan LLP; Heyman Enerio Gattuso & Hirzel LLP; Morris, Nichols, Arsht & Tunnell; Phillips, Goldman, McLaughlin & Hall, P.A.; Prickett, Jones & Elliott, P.A.; Schiff Hardin LLP; Shaw Keller LLP; Stamoulis & Weinblatt LLC; White & Williams
Link to Docket External link to docket
Small Molecule Drugs cited in Amgen Inc. v. Amneal Pharmaceuticals
The small molecule drugs covered by the patents cited in this case are   Start Trial ,   Start Trial , and   Start Trial .
Biologic Drugs cited in Amgen Inc. v. Amneal Pharmaceuticals
The biologic drug covered by the patents cited in this case is   Start Trial .

Details for Amgen Inc. v. Amneal Pharmaceuticals (D. Del. 2016)

Date Filed Document No. Description Snippet Link To Document
0000-00-00 1 Complaint action for infringement of U.S. Patent No. 9,375,405 (the “‘405 patent”). 7. This action… THE PATENT-IN-SUIT 14. United States Patent No. 9,375,405, entitled “Rapid…United States Patent and Trademark Office (“PTO”) on June 28, 2016. A copy of the ‘405 patent is attached…15. The ‘405 patent is assigned to Amgen and Amgen is the owner of the ‘405 patent. …405 patent when Aurobindo Ltd notified Amgen of its Paragraph IV Certification of the ‘405 patent. External link to document
2016-12-15 14 and/or (c). Amgen also owns U.S. Patent No. 6,011,068, which is listed in the Orange Book listing…undergo parathyroidectomy. U.S. Patent No. 9,375,405 (the “’405 patent”) is listed in Approved Drug Products…‘405 patent invalid. 2. A judgment that no asserted claim of the ‘405 patent is infringed…Substance of the Actions These are Hatch-Waxman patent infringement actions relating to cinacalcet hydrochloride…United States prior to the expiration of the ’405 patent. By letter dated August 5, 2016, Aurobindo notified External link to document
0000-00-00 186 Memorandum and Order ORDER Construing the Terms of U.S. Patent No. 9,375,405. Signed by Judge Gregory M. Sleet on 7/19… 22 September 2016 1:16-cv-00853 Patent None District Court, D. Delaware External link to document
0000-00-00 228 Notice of Service Ph.D. Regarding Non-Infringement of U.S. Patent No. 9,375,405 filed by Cadila Healthcare Ltd., Zydus Pharmaceuticals… 22 September 2016 1:16-cv-00853 Patent None District Court, D. Delaware External link to document
0000-00-00 230 Notice of Service Roush, Ph.D. Regarding the Validity of U.S. Patent No. 9,375,405; (3) Rebuttal Expert Report of Dr. Martyn…C. Davies in Support of Validity of U.S. Patent No. 9,375,405; and (4) Rebuttal Expert Report of David… 22 September 2016 1:16-cv-00853 Patent None District Court, D. Delaware External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Mallinckrodt
Medtronic
Moodys
Merck
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.